Martin Shkreli (Dennis Van Tine/Sipa USA, Sipa via AP Images)
Martin Shkreli faces another lawsuit, this time from insurer, alleging plans to create a monopoly for Daraprim
The notorious “Pharma Bro” Martin Shkreli prompted national outrage in 2015 when he and then-Turing Pharmaceuticals raised the price of Daraprim, the “gold standard” treatment …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.